You just read:

Relmada Therapeutics Allowed Patent Application in China Covering NMDA Receptor Antagonist d-Methadone for Treatment of Psychiatric Symptoms

News provided by

Relmada Therapeutics, Inc.

Aug 09, 2018, 08:00 ET